Profile
Home  /   Staff  /   Researcher Profiles  /  Dr Kelly Kiejda  /  Research Funding

Dr Kelly Kiejda

Work Phone 4042 0309
Fax 4042 0031
Email
Office Rm 3104, Lvl 3, West, Hunter Medical Research Institute

Funding

Summary

Number of grants 21
Total funding $1,435,026

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

Seeking students for this project. - Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2013 (2 grants)

The function of the delta-40p53 isoform in breast cancer.$30,000
Funding Body: Hunter Medical Research Institute

miRNA regulation of growth, invasion and treatment response in triple negative breast cancer$10,000
Funding Body: Hunter Medical Research Institute

2012 (5 grants)

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$294,301
Funding Body: Cancer Institute NSW

p53 isoforms in breast cancer - MM Sawyer Estate Scholarship$75,000
Funding Body: Hunter Medical Research Institute

Small p53 isoforms, BIG implications for treatment response in breast cancer$30,000
Funding Body: Hunter Medical Research Institute

2011 Emerging Research Leaders Program$15,000
Funding Body: University of Newcastle

Ninth International NRAi, MicroRNAs & Single Cell Biology - 2012, Hilton Garden Inn, Waltham, Massachusetts, USA, 1 - 2 May 2012$2,000
Funding Body: University of Newcastle - Faculty of Health

2011 (3 grants)

p53 isoforms, a prognostic indicator in breast cancer?$45,000
Funding Body: Hunter Medical Research Institute

PULSE Education Prize$4,000
Funding Body: Hunter Medical Research Institute

Annual meeting fo the Australasian Microarray & Associated Technologies Association (AMATA), Shine Dome in Canberra, 9 - 12 October 2011$1,375
Funding Body: University of Newcastle - Faculty of Health

2010 (1 grants)

The identification of microRNA's as therapeutic targets for the treatment of advanced breast cancer$21,600
Funding Body: Hunter Medical Research Institute

2009 (4 grants)

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000
Funding Body: Cancer Council NSW

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000
Funding Body: Cancer Australia

Targeting p53 isoforms in human melanoma$30,000
Funding Body: Calvary Mater Newcastle

The microRNA signature of endoplasmic reticulum stress in melanoma$10,000
Funding Body: Calvary Mater Newcastle

2007 (3 grants)

Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000
Funding Body: Cure Cancer Australia Foundation

The role of p53 Isoforms in chemoresistances of human melanoma$20,000
Funding Body: Hunter Medical Research Institute

The role of p53 isoforms in chemoresistance of human melanoma$10,000
Funding Body: Calvary Mater Newcastle

2006 (1 grants)

Cameron Fellowship in Melanoma Research$332,000
Funding Body: Melanoma and Skin Cancer Research Institute

2001 (2 grants)

Australian Postgraduate Award$64,750
Funding Body: Department of Education, Training & Youth Affairs

Millennium Foundation Stipend Enhancement Grant$18,000
Funding Body: Millennium Foundation